Pilot Study Comparing Early Conversion to Extended-Release Tacrolimus (ENVARSUS XR) to Immediate-Release Tacrolimus in Lung Transplant Recipients

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Lung Transplant
  • Age: Between 18 years - 75 years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Participants who are age = 18 years
    2. Those who Received a lung or heart-lung transplant at NYU Langone Health
    3. Participants who will be able to convert to Envarsus XR within the first month post-transplant
    4. Participants who are able to provide written informed consent

You may not be eligible for this study if the following are true:

    1. Contraindication to tacrolimus due to allergic or adverse reactions
    2. Pregnant or nursing women



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.